Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner
Ma Carmen Ocaña(Instituto de Investigación Biomédica de Málaga), Miguel Ángel Medina(Centre for Biomedical Network Research on Rare Diseases)
Cited by 39
Related Papers
Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells
|Scientific Reports|2015|50
Glucose Favors Lipid Anabolic Metabolism in the Invasive Breast Cancer Cell Line MDA-MB-231
|Biology|2020|22
What is known on angiogenesis‐related rare diseases? A systematic review of literature
|Journal of Cellular and Molecular Medicine|2012|20
Highly Glycolytic Immortalized Human Dermal Microvascular Endothelial Cells are Able to Grow in Glucose-Starved Conditions
|Biomolecules|2019|10
(+)-Aeroplysinin-1 Modulates the Redox Balance of Endothelial Cells
|Marine Drugs|2018|8